364 related articles for article (PubMed ID: 17417778)
1. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
[TBL] [Abstract][Full Text] [Related]
3. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.
Win AK; Reece JC; Buchanan DD; Clendenning M; Young JP; Cleary SP; Kim H; Cotterchio M; Dowty JG; MacInnis RJ; Tucker KM; Winship IM; Macrae FA; Burnett T; Le Marchand L; Casey G; Haile RW; Newcomb PA; Thibodeau SN; Lindor NM; Hopper JL; Gallinger S; Jenkins MA
Fam Cancer; 2015 Dec; 14(4):575-83. PubMed ID: 26202870
[TBL] [Abstract][Full Text] [Related]
4. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
[TBL] [Abstract][Full Text] [Related]
5. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
[TBL] [Abstract][Full Text] [Related]
6. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.
Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA
Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.
Shia J; Tang LH; Vakiani E; Guillem JG; Stadler ZK; Soslow RA; Katabi N; Weiser MR; Paty PB; Temple LK; Nash GM; Wong WD; Offit K; Klimstra DS
Am J Surg Pathol; 2009 Nov; 33(11):1639-45. PubMed ID: 19701074
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms.
Yuan ZQ; Gottlieb B; Beitel LK; Wong N; Gordon PH; Wang Q; Puisieux A; Foulkes WD; Trifiro M
Hum Mutat; 2002 Feb; 19(2):108-13. PubMed ID: 11793469
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
[TBL] [Abstract][Full Text] [Related]
11. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome.
Guindalini RS; Win AK; Gulden C; Lindor NM; Newcomb PA; Haile RW; Raymond V; Stoffel E; Hall M; Llor X; Ukaegbu CI; Solomon I; Weitzel J; Kalady M; Blanco A; Terdiman J; Shuttlesworth GA; Lynch PM; Hampel H; Lynch HT; Jenkins MA; Olopade OI; Kupfer SS
Gastroenterology; 2015 Nov; 149(6):1446-53. PubMed ID: 26248088
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the oxidative damage repair genes NUDT1, OGG1, and MUTYH in patients from mismatch repair proficient HNPCC families (MSS-HNPCC).
Garre P; Briceño V; Xicola RM; Doyle BJ; de la Hoya M; Sanz J; Llovet P; Pescador P; Puente J; Díaz-Rubio E; Llor X; Caldés T
Clin Cancer Res; 2011 Apr; 17(7):1701-12. PubMed ID: 21355073
[TBL] [Abstract][Full Text] [Related]
13. A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays.
Thompson BA; Martins A; Spurdle AB
Clin Genet; 2015 Feb; 87(2):100-8. PubMed ID: 24989436
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.
Kim IJ; Ku JL; Kang HC; Park JH; Yoon KA; Shin Y; Park HW; Jang SG; Lim SK; Han SY; Shin YK; Lee MR; Jeong SY; Shin HR; Lee JS; Kim WH; Park JG
Hum Genet; 2004 Nov; 115(6):498-503. PubMed ID: 15449173
[TBL] [Abstract][Full Text] [Related]
15. Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome.
Rahner N; Friedrichs N; Wehner M; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
Acta Oncol; 2007; 46(6):763-9. PubMed ID: 17653898
[TBL] [Abstract][Full Text] [Related]
16. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
17. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?
Win AK; Hopper JL; Buchanan DD; Young JP; Tenesa A; Dowty JG; Giles GG; Goldblatt J; Winship I; Boussioutas A; Young GP; Parry S; Baron JA; Duggan D; Gallinger S; Newcomb PA; Haile RW; Le Marchand L; Lindor NM; Jenkins MA
Eur J Cancer; 2013 May; 49(7):1578-87. PubMed ID: 23434150
[TBL] [Abstract][Full Text] [Related]
18. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
[TBL] [Abstract][Full Text] [Related]
19. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
[TBL] [Abstract][Full Text] [Related]
20. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]